Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mortaz (Tehran, Islamic Republic of Iran), A. Asef (Tehran, Islamic Republic of Iran), E. Azempour (Tehran, Islamic Republic of Iran), H. Ghaffaripour (Tehran, Islamic Republic of Iran), I. Adcock (London, United Kingdom), L. Koenderman (Utrecht, Netherlands). Evaluation of neutrophils phagocytosis and killing in pulmonary cystic fibrosis patients. 972

Member's Comments

No comment yet.

Related content which might interest you: Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 Neutrophil functional activity of patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Neutrophil functional activity of patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Distribution and characterisation of lung mast cells in cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients. Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Acute exercise in cystic fibrosis patients increases neutrophilic pulmonary inflammation Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Increased priming of blood neutrophils in children with clinically stable cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs) Source: Eur Respir J 2001; 18: Suppl. 33, 79s Year: 2001 Expansion of small sputum macrophages in cystic fibrosis airways Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001 Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations Source: Eur Respir J 2015; 46: 1055-1064 Year: 2015 Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019